BIOVISTA Inc. ANNOUNCES DRUG REPOSITIONING COLLABORATION WITH ASTELLAS PHARMA

12-11-15

Biovista announced that it has entered into a drug repositioning collaboration with Astellas Pharma Inc. The collaboration is focused on identifying new indications for a number of undisclosed Astellas compounds using Biovista's Clinical Outcome Search Space (COSS) technology.

Please see link below for more information:

http://www.biovista.com/biovista-announces-drug-repositioning-collaboration-astellas-pharma/